Inhibition of renin angiotensin axis may be associated with reduced risk of developing venous thromboembolism in patients with atherosclerotic disease

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Chae, Young Kwang ^a   Khemasuwan, Danai ^b   Dimou, Anastasios ^c   Neagu, Stefan ^c   Chebrolu, Lakshmi ^c   Gupta, Shikha ^c   Carpio, Alejandra ^c   Kim, Jongoh ^c   Yun, Jeong Hyun ^c   Smyrlis, Athanasios ^c   Friedman, Alan ^c   Tester, William ^c  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HORMONE; RENIN;

AFRICAN AMERICAN; AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DRUG USE; FEMALE; FOLLOW UP; HEART INFARCTION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; IMMOBILIZATION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDICAL HISTORY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RETROSPECTIVE STUDY; RISK REDUCTION; SMOKING; TEACHING HOSPITAL; VENOUS THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ATHEROSCLEROSIS; BRAIN ISCHEMIA; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RENIN-ANGIOTENSIN SYSTEM; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; VENOUS THROMBOEMBOLISM;

EID: 84900430885     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0087813     Document Type: Article

References (28)

1. Hansson PO, Welin L, Tibblin G, Eriksson H (1997) Deep vein thrombosis and pulmonary embolism in the general population. 'he Study of Men Born in 1913' Arch Intern Med 157: 1665-1670. (Pubitemid 27327401)
2. Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, et al. (1998) Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med 158: 585-593. (Pubitemid 28144815)
3. Rus HG, Niculescu F, Vlaicu R (1991) Tumor necrosis factor-alpha in human arterial wall with atherosclerosis. Atherosclerosis 89: 247-254.
4. Rus HG, Vlaicu R, Niculescu F (1996) Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 127: 263-271. (Pubitemid 27045840)
5. van Aken BE, den Heijer M, Bos GM, van Deventer SJ, Reitsma PH (2000) Recurrent venous thrombosis and markers of inflammation. Thromb Haemost 83: 536-539. (Pubitemid 30201126)
6. van Aken BE, Reitsma PH, Rosendaal FR (2002) Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis. Br J Haematol 116: 173-177. (Pubitemid 34122078)
7. Lilienberg G, Venge P (1998) Platelet adhesion in patients prone to arterial and venous thrombosis: the impact of gender, smoking and heredity. Scand J Clin Lab Invest 58: 279-286. (Pubitemid 28396215)
8. Prandoni P, Bilora F, Marchiori A, Bernardi E, Petrobelli F, et al. (2003) An association between atherosclerosis and venous thrombosis. N Engl J Med 348: 1435-1441. (Pubitemid 36407172)
9. Hong C, Zhu F, Du D, Pilgram TK, Sicard GA, et al. (2005) Coronary artery calcification and risk factors for atherosclerosis in patients with venous thromboembolism. Atherosclerosis 183: 169-174. (Pubitemid 41416836)
10. Sorensen HT, Horvath-Puho E, Pedersen L, Baron JA, Prandoni P (2007) Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet 370: 1773-1779. (Pubitemid 350137491)
11. Sorensen HT, Horvath-Puho E, Sogaard KK, Christensen S, Johnsen SP, et al. (2009) Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study. J Thromb Haemost 7: 521-528.
12. Ageno W, Becattini C, Brighton T, Selby R, Kamphuisen PW (2008) Cardiovascular risk factors and venous thromboembolism: a meta-analysis. Circulation 117: 93-102. (Pubitemid 350301144)
13. Reich LM, Folsom AR, Key NS, Boland LL, Heckbert SR, et al. (2006) Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolism. J Thromb Haemost 4: 1909-1913. (Pubitemid 44226767)
14. van der Hagen PB, Folsom AR, Jenny NS, Heckbert SR, O'Meara ES, et al. (2006) Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study. J Thromb Haemost 4: 1903-1908. (Pubitemid 44226766)
15. Remkova A, Remko M (2010) The role of renin-angiotensin system in prothrombotic state in essential hypertension. Physiol Res 59: 13-23.
16. Brown NJ, Vaughan DE (2000) Prothrombotic effects of angiotensin. Adv Intern Med 45: 419-429.
17. Chabielska E, Pawlak R, Golatowski J, Buczko W (1998) The antithrombotic effect of captopril and losartan on experimental arterial thrombosis in rats. J Physiol Pharmacol 49: 251-260. (Pubitemid 28331409)
18. Chabielska E, Pawlak R, Golatowski J, Rolkowski R, Pawlak D, et al. (1998) Losartan inhibits experimental venous thrombosis in spontaneously hypertensive rats. Thromb Res 90: 271-278. (Pubitemid 28383788)
19. Thygesen K, Alpert JS, Jaffe AS, White HD (2008) Diagnostic application of the universal definition of myocardial infarction in the intensive care unit. Curr Opin Crit Care 14: 543-548.
20. Hussein AA, Uno K, Wolski K, Kapadia S, Schoenhagen P, et al. (2011) Peripheral arterial disease and progression of coronary atherosclerosis. J Am Coll Cardiol 57: 1220-1225.
21. Boldt J, Knothe C, Schindler F, Stertmann WA, Hempelmann G (1994) Isolated circulatory response to intravenous administration of the ACE inhibitor enalaprilat. Br J Clin Pharmacol 37: 341-346. (Pubitemid 24204597)
22. Battaglioli T, Martinelli I (2007) Hormone therapy and thromboembolic disease. Curr Opin Hematol 14: 488-493. (Pubitemid 47457638)
23. Squizzato A, Galli M, Romualdi E, Dentali F, Kamphuisen PW, et al. (2010) Statins, fibrates, and venous thromboembolism: a meta-analysis. Eur Heart J 31: 1248-1256.
24. Glynn RJ, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, et al. (2009) A randomized trial of rosuvastatin in the prevention of venous thromboembolism. N Engl J Med 360: 1851-1861.
25. Khemasuwan D, Divietro ML, Tangdhanakanond K, Pomerantz SC, Eiger G (2010) Statins decrease the occurrence of venous thromboembolism in patients with cancer. Am J Med 123: 60-65.
26. Karthikeyan G, Eikelboom JW, Turpie AG, Hirsh J (2009) Does acetyl salicylic acid (ASA) have a role in the prevention of venous thromboembolism? Br J Haematol 146: 142-149.
27. Wattanakit K, Cushman M (2009) Chronic kidney disease and venous thromboembolism: epidemiology and mechanisms. Curr Opin Pulm Med 15: 408-412.
28. Mahmoodi BK, Gansevoort RT, Veeger NJ, Matthews AG, Navis G, et al. (2009) Microalbuminuria and risk of venous thromboembolism. JAMA 301: 1790-1797.